As GLP-1 medications have revolutionized the treatment of obesity over the last several years and become increasingly available, Louisiana has lifted a ban on treating the condition via telehealth
Personalized plan: decide between Ozempic, Wegovy, or compounded semaglutide
Through appetite suppression, patients lose weight as they are eating much less food
This has created a competitive landscape where differentiation increasingly focuses on pricing structure, medication format options, and operational transparency regarding how medical decisions are made
Two forms of GLP-1 are secreted in response to a meal: GLP-1(1-37) and GLP-1 (7-36), but the predominant form in the circulation is the truncated form GLP-1(7-36) [7]
This simple tool helps us tailor your treatment plan according to your unique needs and health goals